by David Kent | Feb 6, 2018
In my last post, I drew our readers’ attention to an excellent article by Giulio Cossu and colleagues on stem cells and regenerative medicine where the authors set out a number of recommendations for the regenerative medicine field. One of those recommendations was...
by Mark Curtis | Apr 28, 2015
. After several years of intense systematic research, and toiling with a differentiation protocol, Dr. Doug Melton, and his lab at Harvard University, finally decoded the sequence of genes that needs to be activated to yield mature, insulin-producing beta cells in...
by David Kent | Mar 18, 2015
Earlier this month, Harvard Medical School researchers published a brief report in Cell Stem Cell, which showed in non-human primates – in this case monkeys – that Parkinson’s disease symptoms could be alleviated using stem cell therapy. Using induced pluripotent stem...
by Stacey Johnson | Mar 6, 2015
. The beauty of an infographic (or two) is it speaks for itself. Shared with permission of BioInformant: http://www.bioinformant.com/ Our regular feature, Right Turn, appears every Friday and we invite you to submit your own blog to info(at)ccrm.ca. We...
by Mark Curtis | Nov 27, 2013
. Welcome to the regenerative medicine deal review for the month of November. Cytori Therapeutics and Lorem Vascular have teamed up to catalyze the commercialization of Cytori cell therapies using its proprietary Celution® System in Asia. There was also a notable deal...
Comments